Bio Protocol vs Creditcoin — how do they compare? Bio Protocol trades at Rp515.4 (market cap Rp1,16T, Rp252,63M 24h volume), while Creditcoin trades at Rp1,481 (market cap Rp809,77M, Rp45,58M 24h volume). The key difference: Bio Protocol is far larger — about 1432.5× Creditcoin's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 549,6M / 600M CTC (92%) for Creditcoin. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Creditcoin for 17 Days on average.
| BIO | CTC | |
|---|---|---|
Market Cap | Rp1,16T | Rp809,77M |
Volume (24h) | Rp252,63M | Rp45,58M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 549,6M / 600M CTC (92%) |
Typical Hold Time | 16 Days | 17 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Creditcoin is a project developed by a team based in the United States, Canada, South Korea, Nigeria, and Estonia. Its goal is to address the lack of credit systems for the unbanked in emerging markets. Individuals who are unable to access traditional banking services often have to rely on non-banking sources for loans. However, banks do not accept credit records from these non-banking institutions because they cannot verify the reliability of the data. Creditcoin aims to solve this issue by documenting credit transaction history transparently on a public blockchain, providing a trustworthy record that banks can rely on.
Read more on CTC →